U.S. flag

An official website of the United States government

NM_014874.4(MFN2):c.669T>A (p.Phe223Leu) AND Charcot-Marie-Tooth disease type 2

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jan 9, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003581716.1

Allele description [Variation Report for NM_014874.4(MFN2):c.669T>A (p.Phe223Leu)]

NM_014874.4(MFN2):c.669T>A (p.Phe223Leu)

Gene:
MFN2:mitofusin 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p36.22
Genomic location:
Preferred name:
NM_014874.4(MFN2):c.669T>A (p.Phe223Leu)
HGVS:
  • NC_000001.11:g.11998839T>A
  • NG_007945.1:g.23659T>A
  • NM_001127660.2:c.669T>A
  • NM_014874.4:c.669T>AMANE SELECT
  • NP_001121132.1:p.Phe223Leu
  • NP_055689.1:p.Phe223Leu
  • NP_055689.1:p.Phe223Leu
  • LRG_255t1:c.669T>A
  • LRG_255:g.23659T>A
  • LRG_255p1:p.Phe223Leu
  • NC_000001.10:g.12058896T>A
  • NM_014874.3:c.669T>A
Protein change:
F223L
Links:
dbSNP: rs1440006845
NCBI 1000 Genomes Browser:
rs1440006845
Molecular consequence:
  • NM_001127660.2:c.669T>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_014874.4:c.669T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Charcot-Marie-Tooth disease type 2
Synonyms:
Charcot-Marie-Tooth, Type 2
Identifiers:
MONDO: MONDO:0018993; MedGen: C0270914

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004291591Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jan 9, 2024)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A.

Kijima K, Numakura C, Izumino H, Umetsu K, Nezu A, Shiiki T, Ogawa M, Ishizaki Y, Kitamura T, Shozawa Y, Hayasaka K.

Hum Genet. 2005 Jan;116(1-2):23-7. Epub 2004 Nov 11.

PubMed [citation]
PMID:
15549395

Ethambutol toxicity exacerbating the phenotype of CMT2A2.

Fonkem E, Skordilis MA, Binkley EM, Raymer DS, Epstein A, Arnold WD, Kissel JT, Lawson VH.

Muscle Nerve. 2013 Jul;48(1):140-4. doi: 10.1002/mus.23766. Epub 2013 Jun 4.

PubMed [citation]
PMID:
23733358
See all PubMed Citations (3)

Details of each submission

From Invitae, SCV004291591.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 223 of the MFN2 protein (p.Phe223Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant Charcot-Marie-Tooth disease (PMID: 15549395, 23733358). ClinVar contains an entry for this variant (Variation ID: 637299). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt MFN2 protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024